Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
06/2010
06/17/2010WO2010068383A1 Novel rifamycin 3, 4- (3' -substituted aminomethyl) fused pyrrolo derivatives
06/17/2010WO2010068182A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
06/17/2010WO2010068181A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt
06/17/2010WO2010067102A1 Diazaspiro [5.5] undecane derivatives and related compounds as muscarinic-receptor antagonists and beta-adrenoreceptor agonists for the treatment of pulmonary disorders
06/17/2010WO2010066840A1 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
06/17/2010US20100152441 6-[({1-[2-(7-methoxy-2-oxoquinoxalin-1(2H)-yl)ethyl]piperidin-4-yl}amino)methyl]-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one; antibacteria; methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant coagulase-negative staphylococci (MRCNS), penicillin-resistant Streptococcus pneumoniae
06/17/2010US20100152407 Novel compounds
06/17/2010US20100152267 Novel rifamycin 3,4-(3-substituted aminomethyl) fused pyrrolo derivatives
06/17/2010US20100152176 Modulators of Muscarinic Receptors
06/17/2010US20100152174 Macrocyclic quinazole derivatives and their use as mtki
06/17/2010US20100152112 Quinoline derivatives as p13 kinase inhibitors
06/17/2010US20100152105 Use of rapamycin derivatives in chronic rejection
06/17/2010CA2746058A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt
06/17/2010CA2743557A1 Spiro azepane-oxazolidinones as kv1.3 potassium channel blockers
06/16/2010EP2194983A1 Compounds which have activity at m1 receptor and their uses in medicine
06/16/2010EP2194982A1 Compounds which have activity at m1 receptor and their uses in medicine
06/16/2010CN1989141B Bicyclic heterocycles as HIV integrase inhibitors
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/16/2010CN1863806B 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
06/16/2010CN101099286B Method and installation means for installing an electrical machine
06/15/2010US7737272 Diazaphosphacycle transition metal complexes
06/15/2010US7737172 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections
06/15/2010US7737145 Diamine derivatives as inhibitors of leukotriene A4 hydrolase
06/15/2010US7737136 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives
06/15/2010CA2538915C [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
06/15/2010CA2518224C Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof
06/15/2010CA2383340C Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
06/10/2010WO2010065893A1 Raf inhibitors and their uses
06/10/2010WO2010064020A1 Imidazopyridine compounds
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100144735 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
06/10/2010US20100144717 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
06/10/2010CA2744713A1 Raf inhibitors and their uses
06/09/2010EP2193788A1 Pharmaceutical compositions comprising colloidal silicon dioxide
06/09/2010EP2193118A2 Piperidine and piperazine derivatives for treating tumours
06/09/2010CN1886408B Polymorphous forms of rifaximin, processes for production and use in medicinal preparations
06/09/2010CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia
06/09/2010CN101220039B Chiral center aza ring carbene precursor salt with camphor framework, synthesizing method and uses thereof
06/09/2010CN101048466B Reactive triphendioxazine dyes, methods for the production thereof, and use thereof
06/09/2010CN101031573B Heteroatoms-containing tricyclic compounds
06/09/2010CN101029051B (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the AMPA receptor
06/08/2010US7732610 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
06/08/2010US7732435 vanilloid receptor antagonists such as 7-(4-Chlorophenyl)-6-isopropyl-3-methyl-2,3-dihydro-1H-1-aza-4,5-dioxa-phenanthren-8-one, used for treating nociceptive pain; analgesics
06/08/2010US7732186 Recombinant methods and materials for producing epothilone and epothilone derivatives
06/08/2010US7731760 hair dyes with good fastness properties with respect to washing, light, shampooing and rubbing; storage stability
06/08/2010CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
06/03/2010WO2010060904A1 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases
06/03/2010WO2010060854A1 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
06/03/2010WO2010042391A3 Hiv integrase inhibitors
06/03/2010US20100137591 Process for preparing 3-methyl-4-phenylisoxazolo [3,4-d]pyridazin-7(6h)-one
06/03/2010US20100137580 Process for preparing amorphous rifaximin and the amorphous rifaximin thus obtained
06/03/2010US20100137299 Spiro-oxindole compounds and their use as therapeutic agents
06/03/2010US20100137295 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
06/03/2010US20100137282 Tricyclic nitrogen containing compounds as antibacterial agents
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/02/2010EP2099799B1 Spiro-piperidine derivatives
06/02/2010EP1817317B1 Methods for preparing pimecrolimus
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101717404A Preparation process of levofloxacin carboxylic acid
06/02/2010CN101220044B Telomerase inhibitor, preparation method and application thereof
06/01/2010US7728141 Substituted naphthyridinone derivatives
06/01/2010US7727999 substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds, used as selective serotonin receptor antagonists, used rfor the treatment of schizophrenia, psychosis, headaches, hypertension, thrombosis, vasospasm, depression, anxiety, sleep disorders and appetite disorders
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727983 Oxadiazoanthracene compounds for the treatment of diabetes
06/01/2010US7727275 Drug-delivery endovascular stent and method of forming the same
06/01/2010CA2438547C Isoxazoline derivative and herbicide containing the same as the active ingredient
06/01/2010CA2157427C Oxazoloquinolinone derivatives, their preparation and their therapeutic application
05/2010
05/27/2010WO2010057880A1 Novel herbicides
05/27/2010WO2010026110A3 6-substituted benzoxazines as 5-ht-5a receptor antagonists
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/27/2010US20100130470 Acrylamide derivatives as fab i inhibitors
05/27/2010US20100130440 Antiviral nucleosides
05/27/2010US20100129314 Potent conjugates and hydrophilic linkers
05/26/2010EP2189462A1 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases
05/26/2010EP2188271A2 Heterocyclic compounds and uses as anticancer agents
05/26/2010EP2187888A2 Bicyclic amides for enhancing glutamatergic synaptic responses
05/26/2010EP1951730B1 Heteroalkyl linked pyrimidine derivatives
05/26/2010EP1874783B1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
05/26/2010CN1820011B Use of rapamycin and rapamycin derivatives for the treatment of bone loss
05/26/2010CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors
05/26/2010CN101712686A Method for separating and purifying tacrolimus in fermentation liquor
05/26/2010CN101712685A Refining method of crude tacrolimus
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/20/2010WO2010057101A2 Compounds useful as hiv blockers
05/20/2010WO2010056875A1 Pyridazinones and their use as btk inhibitors
05/20/2010WO2010056849A1 Gamma secretase modulators
05/20/2010WO2010056722A1 Gamma secretase modulators
05/20/2010WO2010056633A2 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/20/2010WO2010055348A1 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
05/20/2010CA2742520A1 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
05/20/2010CA2742486A1 Gamma secretase modulators
05/20/2010CA2742472A1 Gamma secretase modulators
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2186410A1 Isoxazoline derivative and herbicide comprising the same as active ingredient
05/19/2010EP2185568A2 Therapeutic compounds
05/19/2010EP2185567A2 Substituted bicyclolactam compounds
05/19/2010EP2185562A1 Pyrrolopyrimidines
05/19/2010EP2185522A1 Gamma secretase modulators
05/19/2010EP1896488B1 Process for purifying tacrolimus
05/19/2010EP1896485B1 Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 220